Sort   by:  
 Page size 
ProteomicsUrinary Glycoproteomic profiling of Non-Muscle Invasive and Muscle Invasive Bladder Carcinoma Patients reveals distinct N-glycosylation pattern of CD44, MGAM and GINM1
Clinical management of bladder carcinomas (BC) remains a major challenge and demands comprehensive multi-omics analysis for better stratification of the disease. Identification of patients on risk requires identification of signatures predicting prognosis risk of the patients. Understanding the mole...
ORGANISM(S): Homo sapiens (Human) 
2020-09-10 | PXD020078 | Pride
Urothelial carcinoma  n-linked glycoproteomics  urine proteomics  nmibc  mibc 
UnknownHealth care providers' perspectives on delivering gender equity focused family planning program for young married couples in a cluster randomized controlled trial in rural Maharashtra, India.
Not available
S-EPMC7100659 | biostudies-literature
ProteomicsProteomic data of opaque form responsive proteins of Candida albicans ATCC10231
Data represents the raw proteomic data generated by SWATH-MS analysis of Candida albicans (ATCC 10231) opaque form cells.
ORGANISM(S): Candida Albicans Atcc10231 
2022-12-31 | MSV000090980 | MassIVE
ProteomicsDiscovery of a CNS active GSK3 degrader using orthogonally reactive linker screening
Bifunctional targeted protein degraders, also known as Proteolysis Targeting Chimeras (PROTACs), are an emerging drug modality that may offer a new approach to understand and treat neurodegenerative diseases. These molecules have a non-occupancy based, sub-stoichiometric mechanism of action which re...
ORGANISM(S): Homo sapiens (Human) 
2025-10-13 | PXD065750 | Pride
Targeted protein degradation Central nervous system Glycogen synthase kinase 3 Direct-to-biology 
ProteomicsDiscovery of a CNS active GSK3 degrader using orthogonally reactive linker screening
Bifunctional targeted protein degraders, also known as Proteolysis Targeting Chimeras (PROTACs), are an emerging drug modality that may offer a new approach to understand and treat neurodegenerative diseases. These molecules have a non-occupancy based, sub-stoichiometric mechanism of action which re...
ORGANISM(S): Mus musculus (Mouse) 
2025-10-13 | PXD065731 | Pride
Targeted protein degradation Central nervous system Glycogen synthase kinase 3 Direct-to-biology 
ProteomicsDiscovery of a CNS active GSK3 degrader using orthogonally reactive linker screening
Bifunctional targeted protein degraders, also known as Proteolysis Targeting Chimeras (PROTACs), are an emerging drug modality that may offer a new approach to understand and treat neurodegenerative diseases. These molecules have a non-occupancy based, sub-stoichiometric mechanism of action which re...
ORGANISM(S): Homo sapiens (Human) 
2025-10-13 | PXD065722 | Pride
Central nervous system Targeted protein degradation Glycogen synthase kinase 3 Direct-to-biology 
ProteomicsDiscovery of a CNS active GSK3 degrader using orthogonally reactive linker screening
Bifunctional targeted protein degraders, also known as Proteolysis Targeting Chimeras (PROTACs), are an emerging drug modality that may offer a new approach to understand and treat neurodegenerative diseases. These molecules have a non-occupancy based, sub-stoichiometric mechanism of action which re...
ORGANISM(S): Homo sapiens (Human) 
2025-10-13 | PXD065724 | Pride
Targeted protein degradation Central nervous system Glycogen synthase kinase 3 Direct-to-biology 
ProteomicsDiscovery of a CNS active GSK3 degrader using orthogonally reactive linker screening
Bifunctional targeted protein degraders, also known as Proteolysis Targeting Chimeras (PROTACs), are an emerging drug modality that may offer a new approach to understand and treat neurodegenerative diseases. These molecules have a non-occupancy based, sub-stoichiometric mechanism of action which re...
ORGANISM(S): Homo sapiens (Human) 
2025-10-13 | PXD065692 | Pride
Central nervous system Targeted protein degradation Glycogen synthase kinase 3 
ProteomicsBiofilm responsive proteins of Candida albicans ATCC10231
Present study represents the peptide mass data of proteins expressed during biofilm form growth of Candida albicans ATCC10231.
ORGANISM(S): Candida Albicans Atcc10231 
2023-01-06 | MSV000091018 | MassIVE
ProteomicsIdentification of a Highly Cooperative PROTAC Degrader Targeting GTP-loaded KRAS(on) Alleles
Kirsten rat sarcoma viral oncogene homolog (KRAS) is a frequently mutated oncogene in multiple types of cancer and is a high priority target for oncology drug development. There are many different KRAS mutations, including mutations which favour the GTP-loaded ‘active’ state of KRAS, (KRAS(on)), tha...
ORGANISM(S): Homo sapiens (Human) 
2025-11-24 | PXD065163 | Pride
Targeted protein degradation Kras Protac Cooperativity 
Sort   by:  
 Page size